Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus

NCT07122180 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

72

Enrollment

NETWORK

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DEVICE: CT3 Series Continuous Glucose Monitoring System:

Sponsor

MDCECRO LLC